Friday, February 25, 2011

2/26 TE-RegenMed-StemCell feed

     
    TE-RegenMed-StemCell feed    
   
How to Get from Here to There: Macrophage Recruitment in Alzheimer's Disease.
February 25, 2011 at 8:39 PM
 

How to Get from Here to There: Macrophage Recruitment in Alzheimer's Disease.

Curr Alzheimer Res. 2011 Feb 23;

Authors: Rezai-Zadeh K, Gate D, Gowing G, Town T

Alzheimer's disease (AD) is pathologically defined by presence of intracellular neurofibrillary tangles and extracellular amyloid plaques comprised of amyoid-β (Aβ) peptides. Despite local recruitment of brain microglia to sites of amyloid deposition, these mononuclear phagocytes ultimately fail at restricting β-amyloid plaque formation. On the other hand, it is becoming increasingly clear that professional phagocytes from the periphery possess Aβ clearance aptitude. Yet, in order to harness this beneficial innate immune response, effective strategies must be developed to coax monocytes/macrophages from the periphery into the brain. It has previously been suggested that Aβ 'immunotherapy' clears cerebral Aβ deposits via mononuclear phagocytes, and recent evidence suggests that targeting transforming growth factor-β-Smad 2/3 signaling and chemokine pathways such as Ccr2 impacts blood-to-brain trafficking of these cells in transgenic mouse models of AD. It has also been shown that the fractalkine receptor (Cx3cr1) pathway plays a critical role in chemotaxis of mononuclear phagocytes toward neurons destined for death in AD model mice. In order to translate these basic science findings into AD treatments, a key challenge will be to develop a new generation of pharmacotherapeutics that safely and effectively promote recruitment of peripheral amyloid phagocytes into the AD brain.

PMID: 21345166 [PubMed - as supplied by publisher]

   
   
Evidence for mesenchymal-epithelial transition associated with mouse hepatic stem cell differentiation.
February 25, 2011 at 8:39 PM
 

Evidence for mesenchymal-epithelial transition associated with mouse hepatic stem cell differentiation.

PLoS One. 2011;6(2):e17092

Authors: Li B, Zheng YW, Sano Y, Taniguchi H

Mesenchymal-epithelial transition events are related to embryonic development, tissue construction, and wound healing. Stem cells are involved in all of these processes, at least in part. However, the direct evidence of mesenchymal-epithelial transition associated with stem cells is unclear. To determine whether mesenchymal-epithelial transition occurs in liver development and/or the differentiation process of hepatic stem cells in vitro, we analyzed a variety of murine liver tissues from embryonic day 11.5 to adults and the colonies derived from hepatic stem/progenitor cells isolated with flow cytometry. The results of gene expression, immunohistochemistry and Western blot showed that as liver develops, the expression of epithelial markers such as Cytokeratin18 and E-cadherin increase, while expression of mesenchymal markers such as vimentin and N-cadherin decreased. On the other hand, in freshly isolated hepatic stem cells, the majority of cells (65.0%) co-express epithelial and mesenchymal markers; this proportion is significantly higher than observed in hematopoietic cells, non-hematopoietic cells and non-stem cell fractions. Likewise, in stem cell-derived colonies cultured over time, upregulation of epithelial genes (Cytokeratin-18 and E-cadherin) occurred simultaneously with downregulation of mesenchymal genes (vimentin and Snail1). Furthermore, in the fetal liver, vimentin-positive cells in the non-hematopoietic fraction had distinct proliferative activity and expressed early the hepatic lineage marker alpha-fetoprotein. CONCLUSION: Hepatic stem cells co-express mesenchymal and epithelial markers; the mesenchymal-epithelial transition occurred in both liver development and differentiation of hepatic stem/progenitor cells in vitro. Besides as a mesenchymal marker, vimentin is a novel indicator for cell proliferative activity and undifferentiated status in liver cells.

PMID: 21347296 [PubMed - in process]

   
   
Osteoblast Connexin43 Modulates Skeletal Architecture by Regulating Both Arms of Bone Remodeling.
February 25, 2011 at 8:39 PM
 

Osteoblast Connexin43 Modulates Skeletal Architecture by Regulating Both Arms of Bone Remodeling.

Mol Biol Cell. 2011 Feb 23;

Authors: Watkins M, Grimston SK, Norris JY, Guillotin B, Shaw A, Beniash E, Civitelli R

Connexin43 (Cx43) has an important role in skeletal homeostasis, and Cx43 gene (Gja1) mutations have been linked to oculodentodigital dysplasia (ODDD), a human disorder characterized by prominent skeletal abnormalities. To determine the function of Cx43 at early steps of osteogenesis and its role in the ODDD skeletal phenotype, we have used the Dermo1 promoter to drive Gja1 ablation or induce an ODDD mutation in the chondro-osteogenic linage. Both Gja1 null and ODDD mutant mice develop age-related osteopenia, primarily due to a progressive enlargement of the medullary cavity and cortical thinning. This phenotype is the consequence of a high bone turnover state, with increased endocortical osteoclast mediated bone resorption and increased periosteal bone apposition. Increased bone resorption is a non-cell autonomous defect, caused by exuberant stimulation of osteoclastogenesis by Cx43-deficient bone marrow stromal cells, via decreased Opg production. The latter is part of a broad defect in osteoblast differentiation and function, which also results in abnormal structural and material properties of bone leading to decreased resistance to mechanical load. Thus, Cx43 in osteogenic cells is a critical regulator of both arms of the bone remodeling cycle, its absence causing structural changes remindful of aged or disused bone.

PMID: 21346198 [PubMed - as supplied by publisher]

   
   
Reliability of Upper Extremity Kinematics While Performing Different Tasks in Individuals With Stroke.
February 25, 2011 at 8:39 PM
 

Reliability of Upper Extremity Kinematics While Performing Different Tasks in Individuals With Stroke.

J Mot Behav. 2011 Feb 23;:1

Authors: Patterson TS, Bishop MD, McGuirk TE, Sethi A, Richards LG

Assessments of upper extremity performance typically include qualitative rather than quantitative measures of functional ability. Kinematic analysis is an objective, discriminative measure that quantifies movement biomechanics; however, the use within the poststroke impaired upper extremity is not well established. The purpose of this study was to examine the reliability of upper extremity kinematics in 18 individuals with stroke and 9 healthy controls. Participants performed reaching and grasping tasks over 2 separate days and metrics included movement time, peak velocity, index of curvature, trunk displacement, maximum aperture, and percentage of the movement cycle where maximum aperture occurred. The results showed moderate to high intraclass correlation and low standard error of measurement values for most variables, demonstrating that kinematic analysis may be a feasible and useful tool to quantify upper extremity movement after stroke.

PMID: 21347950 [PubMed - as supplied by publisher]

   
   
Do patients with complete transposition of the great arteries and severe pulmonary hypertension benefit from an arterial switch operation?
February 25, 2011 at 8:39 PM
 

Do patients with complete transposition of the great arteries and severe pulmonary hypertension benefit from an arterial switch operation?

Ann Thorac Surg. 2011 Jan;91(1):181-6

Authors: Fan H, Hu S, Zheng Z, Li S, Zhang Y, Pan X, Liu Y

Whether an arterial switch operation benefits patients with transposition of the great arteries and severe pulmonary hypertension (PH) remains controversial. Therefore, we evaluated the relationship between preoperative PH and early and midterm clinical outcomes after an arterial switch procedure.

PMID: 21172509 [PubMed - indexed for MEDLINE]

   
   
Cell fate conversion by mRNA.
February 25, 2011 at 8:39 PM
 

Cell fate conversion by mRNA.

Stem Cell Res Ther. 2011 Feb 9;2(1):5

Authors: Li M, Sancho-Martinez I, Belmonte JC

ABSTRACT: Recent development of a synthetic mRNA-based technology for efficient reprogramming to pluripotency and cell fate conversion without any modification to the genome has generated great interest among researchers and clinicians alike. It is hoped that this technology could contribute to unmet needs on several fronts of regenerative medicine, including mechanistic study of reprogramming, generation of safe induced pluripotent stem cells suitable for clinical applications, and derivation of desired cell types for cell-replacement therapy. We will discuss the technological advancements made by this synthetic mRNA methodology, its implications, as well as the challenges that lie ahead in the field of regenerative medicine.

PMID: 21345255 [PubMed - as supplied by publisher]

   
   
Engineering a stem cell house into a home.
February 25, 2011 at 8:39 PM
 

Engineering a stem cell house into a home.

Stem Cell Res Ther. 2011 Jan 31;2(1):3

Authors: Gilbert PM, Blau HM

ABSTRACT: In the body, tissue homeostasis is established and maintained by resident tissue-specific adult stem cells (aSCs). Through preservation of bidirectional communications with the surrounding niche and integration of biophysical and biochemical cues, aSCs actively direct the regeneration of aged, injured and diseased tissues. Currently, the ability to guide the behavior and fate of aSCs in the body or in culture after prospective isolation is hindered by our poor comprehension of niche composition and the regulation it imposes. Two-and three-dimensional biomaterials approaches permit systematic analysis of putative niche elements as well as screening approaches to identify novel regulatory mechanisms governing stem cell fate. The marriage of stem cell biology with creative bioengineering technology has the potential to expand our basic understanding of stem cell regulation imposed by the niche and to develop novel regenerative medicine applications.

PMID: 21345268 [PubMed - as supplied by publisher]

   
   
A modified technique for partial pneumonectomy in the mouse.
February 25, 2011 at 8:39 PM
 

A modified technique for partial pneumonectomy in the mouse.

J Invest Surg. 2011;24(2):81-6

Authors: Jackson SR, Williams GN, Lee J, Baer JF, Warburton D, Driscoll B

ABSTRACT Background: Partial pneumonectomy (PNX) in mice results in compensatory growth in the remaining lung and is a useful model for lung repair. However, common pitfalls to the technique present a challenge for researchers. A complete description of murine PNX is thus provided, with a modification that, in our hands, enhanced animal survival. Materials and Methods: 10 ± 2 weeks old mice were anesthetized using 5% inhalational isoflurane via tracheotomy. Mechanical ventilation was provided using a Harvard Model 687 ventilator. In a procedure optimized to be performed in ≤20 min, left lateral thoracotomy was used to access to the left lung, which was grasped with a blunt forceps just distal to the hilum and clipped using a single 5-mm neuro clip. The left lung was resected, leaving a small rim of lung tissue immediately adjacent to the clip. The thoracotomy was closed, and while anesthesia was titrated, sterile saline was injected subcutaneously to replace insensible fluid losses. Upon return of spontaneous breaths, the trachea was decannulated, and the tracheotomy was closed. Results: Even when performed by a single operator, this modified technique produced a survival rate of >85% during the procedure and >90% up to seven days postoperatively in wild-type C57BL/6J mice. Conclusions: Minimizing the time required to perform left lobe pneumonectomy is critical for animal survival. Using a 5-mm neuro clip, rather than silk suture, to isolate the lobe streamlines the procedure, helps reduce cardiac arrythmia, and results in significantly increased rates of intraoperative and immediate postoperative survival.

PMID: 21345008 [PubMed - in process]

   
   
Core-sheath-structured fibers with pDNA polyplex loadings for optimal release profile and transfection efficiency as potential tissue engineering scaffolds.
February 25, 2011 at 7:06 PM
 

Core-sheath-structured fibers with pDNA polyplex loadings for optimal release profile and transfection efficiency as potential tissue engineering scaffolds.

Acta Biomater. 2011 Feb 20;

Authors: Yang Y, Li X, Cheng L, He S, Zou J, Chen F, Zhang Z

Emulsion electrospinning was initially applied to prepare core-sheath structured fibers with the core-loading of pDNA or pDNA polyplexes into fiber sheath of poly(DL-lactide)-poly(ethylene glycol) (PELA). The inoculations of poly(ethylene imine) (PEI) and poly(ethylene glycol) (PEG) were expected to modulate the release profiles, and achieve a balance between the cytotoxicity and transfection efficiency. The core-sheath fibers enhance the structural integrity and biological activity retention of pDNA during the electrospinning process, incubation in release buffer and enzyme digestion. The addition of hydrophilic PEI into fiber matrices accelerates pDNA release, while the encapsulation of pDNA polyplexes within fibers leads no more release after initial burst release. However, a sustained release of pDNA polyplexes has been achieved through PEG incorporation, and the effective release lifetime can be controlled between 6 and 25 d, dependent on the loading amount and molecular weight of PEG. Higher N/P ratios of PEI to DNA result in lower cell attachment ability, and the cell viability is dependent on the effective concentration of pDNA polyplexes released from fibers. While no apparent transfection is detected for pDNA-loaded PELA fibers, PEG inoculations into fibers containing pDNA polyplexes lead over one order of magnitude increase in the transfection efficiency. It is indicated that pDNA polyplexes-loaded fibers with the inoculation of 10% PEG show the best performance in balancing the transfection efficiency and cell viability. It is suggested that electrospun core-sheath fibers integrated with DNA condensation techniques provide potentials for inductive tissue engineering scaffolds to manipulate desired signals at effective levels within the local tissue microenvironment.

PMID: 21345386 [PubMed - as supplied by publisher]

   
   
State of the art in topical wound-healing products.
February 25, 2011 at 7:06 PM
 

State of the art in topical wound-healing products.

Plast Reconstr Surg. 2011 Jan;127 Suppl 1:44S-59S

Authors: Fan K, Tang J, Escandon J, Kirsner RS

Chronic wounds represent a significant medical burden. Such wounds fail to normally progress through the stages of healing, often complicated by a proinflammatory milieu caused by increased proteinases, hypoxia, and bacterial burden. As a result, several modalities, such as dressings, antimicrobials, growth factors, and human skin substitutes, have been devised in an attempt to correct the chronic wound environment. This review addresses these modalities with a focus on evidence and randomized controlled trials.

PMID: 21200273 [PubMed - indexed for MEDLINE]

   
   
Controlled Release of IGF-1 and HGF from a Biodegradable Polyurethane Scaffold.
February 25, 2011 at 7:06 PM
 

Controlled Release of IGF-1 and HGF from a Biodegradable Polyurethane Scaffold.

Pharm Res. 2011 Feb 23;

Authors: Nelson DM, Baraniak PR, Ma Z, Guan J, Mason NS, Wagner WR

PURPOSE: Biodegradable elastomers, which can possess favorable mechanical properties and degradation rates for soft tissue engineering applications, are more recently being explored as depots for biomolecule delivery. The objective of this study was to synthesize and process biodegradable, elastomeric poly(ester urethane)urea (PEUU) scaffolds and to characterize their ability to incorporate and release bioactive insulin-like growth factor-1 (IGF-1) and hepatocyte growth factor (HGF). METHODS: Porous PEUU scaffolds made from either 5 or 8 wt% PEUU were prepared with direct growth-factor incorporation. Long-term in vitro IGF-1 release kinetics were investigated in saline or saline with 100 units/ml lipase to simulate in vivo degradation. Cellular assays were used to confirm released IGF-1 and HGF bioactivity. RESULTS: IGF-1 release into saline occurred in a complex multi-phasic manner for up to 440 days. Scaffolds generated from 5 wt% PEUU delivered protein faster than 8 wt% scaffolds. Lipase-accelerated scaffold degradation led to delivery of >90% protein over 9 weeks for both polymer concentrations. IGF-1 and HGF bioactivity in the first 3 weeks was confirmed. CONCLUSIONS: The capacity of a biodegradable elastomeric scaffold to provide long-term growth-factor delivery was demonstrated. Such a system might provide functional benefit in cardiovascular and other soft tissue engineering applications.

PMID: 21347565 [PubMed - as supplied by publisher]

   
   
Identification of molecular markers for articular cartilage.
February 25, 2011 at 7:06 PM
 

Identification of molecular markers for articular cartilage.

Osteoarthritis Cartilage. 2010 Dec;18(12):1630-8

Authors: Hissnauer TN, Baranowsky A, Pestka JM, Streichert T, Wiegandt K, Goepfert C, Beil FT, Albers J, Schulze J, Ueblacker P, Petersen JP, Schinke T, Meenen NM, Pörtner R, Amling M

The aim of the current study was to identify molecular markers for articular cartilage (AC) that can be used as tools for the quality control of tissue engineered (TE) cartilage.

PMID: 20950698 [PubMed - indexed for MEDLINE]

   
   
Tissue-engineered cardiac constructs for cardiac repair.
February 25, 2011 at 7:06 PM
 

Tissue-engineered cardiac constructs for cardiac repair.

Ann Thorac Surg. 2011 Jan;91(1):320-9

Authors: Miyagawa S, Roth M, Saito A, Sawa Y, Kostin S

Several recent basic research studies have described surgical methods for cardiac repair using tissue cardiomyoplasty. This review summarizes recent advances in cardiac repair using bioengineered tissue from the viewpoint of the cardiac surgeon. We conclude that the results of many basic and preclinical studies indicate that bioengineered tissue can be adapted to conventional surgical techniques. However, no clinical studies have yet proved bioengineered tissue is effective as a treatment for human heart failure. Today's cardiac surgeons can look forward to the advent of new techniques to benefit patients who respond poorly to existing treatment for heart failure.

PMID: 21172551 [PubMed - indexed for MEDLINE]

   
   
Glyoxal Crosslinking of Cell-Seeded Chitosan/Collagenn Hydrogels for Bone Regeneration.
February 25, 2011 at 7:06 PM
 

Glyoxal Crosslinking of Cell-Seeded Chitosan/Collagenn Hydrogels for Bone Regeneration.

Acta Biomater. 2011 Feb 20;

Authors: Wang L, Stegemann JP

Chitosan and collagen are natural biomaterials that have been used extensively in tissue engineering, both separately and as composite materials. Most methods to fabricate chitosan/collagen composites use freeze drying and chemical crosslinking to create stable porous scaffolds, which subsequently can be seeded with cells. In this study, we directly embedded human bone marrow stem cells (hBMSC) in chitosan/collagen materials by initiating gelation using β-glycerophosphate at physiological temperature and pH. We further examined the use of glyoxal, a dialdehyde with relatively low toxicity, to crosslink these materials and characterized the resulting changes in matrix and cell properties. The cytocompatibility of glyoxal and the crosslinked gels were investigated in terms of hBMSC metabolic activity, viability, proliferation, and osteogenic differentiation. These studies revealed that glyoxal was cytocompatible at concentrations below about 1 mM for periods of exposure up to 15 h, though the degree of cell spreading and proliferation were dependent on matrix composition. Glyoxal-crosslinked matrices were stiffer and compacted less than uncrosslinked controls. It was further demonstrated that hBMSC can attach and proliferate in 3D matrices composed of 50/50 chitosan/collagen, and that these materials supported osteogenic differentiation in response to stimulation. Such glyoxal-crosslinked chitosan/collagen composite materials may find utility as cell delivery vehicles for enhancing the repair of bone defects.

PMID: 21345389 [PubMed - as supplied by publisher]

   
   
Investigation of Cell-Substrate Interactions by Focused Ion Beam (FIB) Preparation and Scanning Electron Microscopy (SEM).
February 25, 2011 at 7:06 PM
 

Investigation of Cell-Substrate Interactions by Focused Ion Beam (FIB) Preparation and Scanning Electron Microscopy (SEM).

Acta Biomater. 2011 Feb 20;

Authors: Friedmann A, Hoess A, Cismak A, Heilmann A

Cell-substrate interactions, which are an important issue in tissue engineering, are studied by using focused ion beam (FIB) milling and scanning electron microscopy (SEM) investigations. Sample cross-sections are generated on predefined positions (target preparation), to investigate the interdependency of growing cells with the substrate material. The experiments focus on two cell culturing systems, hepatocytes (HepG2) on nanoporous aluminum oxide (alumina) membranes and mouse fibroblasts (L929) as well as primary nerve cells on silicon chips with microneedles. On these soft/hard hybrid systems, cross-sections cannot be prepared by conventional techniques like microtomy. Morphological investigations of hepatocytes growing on nanoporous alumina membranes demonstrate that there is an ingrowth of microvilli from the cell surfaces into porous membranes having pore diameters larger than 200 nm. Furthermore, at various cell cultures on the microneedle arrays, the contact between the cells and the microneedles can be observed with high resolution. Based on FIB milled cross-sections and SEM micrographs, it can be clearly distinguished between cells which are only in contact with microneedles and cells which are penetrated by microneedles. Especially, target preparation of biological samples with FIB technique offers the possibility to prepare not only soft material but also hybrid samples (soft/hard materials). Followed by high resolution imaging with SEM, new insights into cell surface interactions can be received.

PMID: 21345385 [PubMed - as supplied by publisher]

   
   
Hyperbranched poly(NIPAM) polymers modified with antibiotics for the reduction of bacterial burden in infected human tissue engineered skin.
February 25, 2011 at 7:06 PM
 

Hyperbranched poly(NIPAM) polymers modified with antibiotics for the reduction of bacterial burden in infected human tissue engineered skin.

Biomaterials. 2011 Jan;32(1):258-67

Authors: Shepherd J, Sarker P, Rimmer S, Swanson L, MacNeil S, Douglas I

The escalating global incidence of bacterial infection, particularly in chronic wounds, is a problem that requires significant improvements to existing therapies. We have developed hyperbranched poly(NIPAM) polymers functionalized with the antibiotics Vancomycin and Polymyxin-B that are sensitive to the presence of bacteria in solution. Binding of bacteria to the polymers causes a conformational change, resulting in collapse of the polymers and the formation of insoluble polymer/bacteria complexes. We have applied these novel polymers to our tissue engineered human skin model of a burn wound infected with Pseudomonas aeruginosa and Staphylococcus aureus. When the polymers were removed from the infected skin, either in a polymer gel solution or in the form of hydrogel membranes, they removed bound bacteria, thus reducing the bacterial load in the infected skin model. These bacteria-binding polymers have many potential uses, including coatings for wound dressings.

PMID: 20933276 [PubMed - indexed for MEDLINE]

   
   
Electrospun scaffolds of self-assembling peptides with poly(ethylene oxide) for bone tissue engineering.
February 25, 2011 at 7:06 PM
 

Electrospun scaffolds of self-assembling peptides with poly(ethylene oxide) for bone tissue engineering.

Acta Biomater. 2011 Feb 20;

Authors: Brun P, Ghezzo F, Roso M, Danesin R, Palù G, Bagno A, Modesti M, Castagliuolo I, Dettin M

Searching for suitable extracellular matrix substitutes, structural, mechanical and biochemical properties have to be considered. Fibrous structures of synthetic or natural polymers received increasing interest as 3D-scaffold for tissue engineering applications: they can be easily produced by electrospinning with different topographical features by changing process parameters. On the other hand, the nanobiotechnology approach suggests to mimic molecular architectures in nature through self-assembling process. In particular self-assembling peptide-based biomaterials have been successfully used as scaffolds for cell growth. In order to join these two strategies, nano-fibrous electrospun scaffolds of hybrid polymer were designed and obtained by mixing poly(ethylene oxide) and self-assembling peptides in aqueous solution. The results of in vitro osteoblast adhesion and proliferation assays on the electrospun scaffolds obtained with different self-assembling peptide sequences are discussed in this paper.

PMID: 21345384 [PubMed - as supplied by publisher]

   
   
BMP-2 Gene Modified Canine bMSCs Promote Ectopic Bone Formation Mediated by a Nonviral PEI Derivative.
February 25, 2011 at 7:06 PM
 

BMP-2 Gene Modified Canine bMSCs Promote Ectopic Bone Formation Mediated by a Nonviral PEI Derivative.

Ann Biomed Eng. 2011 Feb 23;

Authors: Lü K, Zeng D, Zhang Y, Xia L, Xu L, Kaplan DL, Jiang X, Zhang F

The study was to explore the effects of BMP-2 gene modified canine bone marrow stromal cells (bMSCs) mediated by a nonviral PEI derivative (GenEscort™ II) in promoting bone formation in vitro and in vivo. Canine bMSCs were cultured and transfected with plasmids containing bone morphogenetic protein-2 gene (pBMP-2) or enhanced green fluorescent protein gene (pEGFP). Gene transfection conditions were initially optimized by varying GenEscort™ II/plasmid ratios. Osteogenic differentiation of gene modified bMSCs was investigated via alkaline phosphatase (ALP) activity analysis and real-time quantitative PCR (RT-qPCR) analysis in vitro. The bone formation ability of pBMP-2 transfected bMSCs combined with apatite-coated silk scaffolds (mSS) was explored and compared with pEGFP transfected bMSCs/mSS or untreated bMSCs/mSS at 8, 12 weeks after operation. Results showed that gene transfection efficiency reached up to 36.67 ± 4.12% as demonstrated by EGFP expression. ALP staining and activity assay were stronger with pBMP-2 gene transfection, and the mRNA expression of BMP-2, bone sialoprotein (BSP), Runt-related transcription factor 2 (Runx-2), and osteopontin (OPN) up-regulated in bMSCs 3, 6, 9 days in pBMP-2 group. Besides, the tissue-engineered bone complex with pBMP-2 modified bMSCs achieved significantly increased de novo bone formation compared with control groups (p < 0.01). We conclude that pBMP-2 transfection mediated by GenEscort™ II could enhance the osteogenic differentiation of canine bMSCs and promote the ectopic new bone formation in nude mice. GenEscort™ II mediated pBMP-2 gene transfer appears to be a safe and effective nonviral method for gene enhanced bone tissue engineering.

PMID: 21347550 [PubMed - as supplied by publisher]

   
   
Discussion. Bioengineered skin constructs and their use in wound healing.
February 25, 2011 at 7:06 PM
 

Discussion. Bioengineered skin constructs and their use in wound healing.

Plast Reconstr Surg. 2011 Jan;127 Suppl 1:91S-92S

Authors: Veves A

PMID: 21200277 [PubMed - indexed for MEDLINE]

   
   
Discussion. Template for skin regeneration.
February 25, 2011 at 7:06 PM
 

Discussion. Template for skin regeneration.

Plast Reconstr Surg. 2011 Jan;127 Suppl 1:71S-74S

Authors: Janis JE, Steinberg JS

PMID: 21200275 [PubMed - indexed for MEDLINE]

   
   
How allograft tissue is regulated.
February 25, 2011 at 7:06 PM
 

How allograft tissue is regulated.

OR Manager. 2010 Dec;26(12):17

Authors:

PMID: 21250562 [PubMed - indexed for MEDLINE]

   
   
Biologic scaffolds for constructive tissue remodeling.
February 25, 2011 at 7:06 PM
 

Biologic scaffolds for constructive tissue remodeling.

Biomaterials. 2011 Jan;32(1):316-9

Authors: Badylak SF, Brown BN, Gilbert TW, Daly KA, Huber A, Turner NJ

PMID: 21125721 [PubMed - indexed for MEDLINE]

   
   
Template for skin regeneration.
February 25, 2011 at 7:06 PM
 

Template for skin regeneration.

Plast Reconstr Surg. 2011 Jan;127 Suppl 1:60S-70S

Authors: Yannas IV, Orgill DP, Burke JF

Advances in critical care allowed survival of large total body surface burn patients in the 1970s, spawning the development of artificial skin for burn victims. Lack of dermis resulted in severe scarring and contractures. The physicochemical properties that are critical to dermal regeneration have subsequently been described, and a dermal regeneration template has been developed.

PMID: 21200274 [PubMed - indexed for MEDLINE]

   
   
The effect of degradable polymer surfaces on co-cultures of monocytes and smooth muscle cells.
February 25, 2011 at 7:06 PM
 

The effect of degradable polymer surfaces on co-cultures of monocytes and smooth muscle cells.

Biomaterials. 2011 Feb 21;

Authors: McBane JE, Battiston KG, Wadhwani A, Sharifpoor S, Labow RS, Santerre JP

Strategies to optimize biomaterial chemistry for applications in vascular tissue engineering attempt to promote endothelial and smooth muscle cell recruitment into porous material constructs. The primary objective is to facilitate relevant tissue formation in a wound healing versus pro-inflammatory manner. The present work investigated the interactive co-cellular response of human monocytes and human vascular smooth muscle cells (VSMCs) with a novel degradable, polar/hydrophobic/ionic (D-PHI) polyurethane and compared it to a commercially available biomaterial, poly-lactic-glycolic acid (PLGA) as well as tissue culture polystyrene (TCPS). D-PHI triggered a smaller pro-inflammatory response (acid phosphatase, esterase, tumor necrosis factor-α) at later time points (>14 d) than PLGA suggesting that monocytes may be transitioning to a more wound-healing phenotype on the D-PHI surface. When D-PHI was coated with collagen, monocyte cell attachment did not differ with the native D-PHI; however, PLGA showed significant differences between collagen coated versus uncoated surfaces. There were more VSMCs and monocytes attached in co-culture to D-PHI when compared to PLGA. Co-cultures on D-PHI released more IL-10 (anti-inflammatory) than monocytes cultured alone, while the VSMCs retained the expression of its marker protein calponin. Together the above data suggest that co-culturing monocytes with VSMCs may aid in stimulating the attachment of VSMCs to D-PHI while eliciting the desired functional phenotypes for both monocytes (i.e. low inflammation based on IL-10 values) and VSMCs (expressing calponin, a marker of contractility). Moreover, the results of this study demonstrated that D-PHI performed equally or better to PLGA in terms of the assayed biological parameters.

PMID: 21345489 [PubMed - as supplied by publisher]

   
   
The continuing evolution of biomaterials.
February 25, 2011 at 7:06 PM
 

The continuing evolution of biomaterials.

Biomaterials. 2011 Jan;32(1):1-2

Authors: Williams D

PMID: 20933267 [PubMed - indexed for MEDLINE]

   
   
Stem cells in dentistry and medicine: the dentist's role.
February 25, 2011 at 7:06 PM
 

Stem cells in dentistry and medicine: the dentist's role.

Dent Today. 2011 Jan;30(1):128, 130-4; quiz 135

Authors: Krasner P, Verlander P

Research has shown that teeth are a source of high quality stem cells that may be used for the treatment of medical and dental disease. The discovery that odontogenic tissues are a source of adult stem cells has opened up a new role for dentists in the field of medicine. Dentists are positioned to become one of the key providers of stem cells, and as a result, their linkage with the medical field will become very intimate. Dental stem cells have the potential to be used in the treatment of a full range of oral pathoses. Dentists can be involved in the extraction, collection, and storage of the stem cells from their patients' teeth. Ongoing research suggests that these stem cells will soon be used for dental purposes such as to replace lost bone around teeth, periodontal ligament or dental pulp; treat periodontal disease; and someday even produce new teeth, as well as for medical applications. In order for dentists to fully participate in this new role, they should become aware of the applications, clinical use, and banking of dental stem cells.

PMID: 21306072 [PubMed - indexed for MEDLINE]

   
   
Porosity and Pore Size Regulate the Degradation Product Profile of Polylactide.
February 25, 2011 at 7:06 PM
 

Porosity and Pore Size Regulate the Degradation Product Profile of Polylactide.

Biomacromolecules. 2011 Feb 23;

Authors: Odelius K, Höglund A, Kumar S, Hakkarainen M, Ghosh AK, Bhatnagar N, Albertsson AC

Porosity and pore size regulated the degradation rate and the release of low molar mass degradation products from porous polylactide (PLA) scaffolds. PLA scaffolds with porosities above 90% and different pore size ranges were subjected to hydrolytic degradation and compared to their solid analog. The solid film degraded fastest and the degradation rate of the porous structures decreased with decreasing pore size. Degradation products were detected earlier from the solid films compared to the porous structures as a result of the additional migration path within the porous structures. An intermediate degradation rate profile was observed when the pore size range was broadened. The morphology of the scaffolds changed during hydrolysis where the larger pore size scaffolds showed sharp pore edges and cavities on the scaffold surface. In the scaffolds with smaller pores, the pore size decreased during degradation and a solid surface was formed on the top of the scaffold. Porosity and pore size, thus, influenced the degradation and the release of degradation products that should be taken into consideration when designing porous scaffolds for tissue engineering.

PMID: 21344847 [PubMed - as supplied by publisher]

   
   
Determining Cell Seeding Dosages for Tissue Engineering Human Pulmonary Valves.
February 25, 2011 at 7:06 PM
 

Determining Cell Seeding Dosages for Tissue Engineering Human Pulmonary Valves.

J Surg Res. 2010 Dec 23;

Authors: Frank BS, Toth PB, Wells WK, McFall CR, Cromwell ML, Hilbert SL, Lofland GK, Hopkins RA

BACKGROUND: This study examines in vitro seeding of decellularized human pulmonary valves (hPVs) with human valve interstitial cells (hVICs) isolated from unrelated donor aortic valve leaflets. An assay was developed to assess seeding using precut uniform sized biopsies from whole hPVs for sequential evaluation of seeding efficiency, proliferation, and migration. MATERIALS AND METHODS: Scaffolds for seeding were created from decellularized hPVs using a reciprocating osmolality, double detergent, enzyme, multiple solvent protocol. hVICs seeded decellularized leaflet and sinus wall scaffolds were incubated in either static or cyclic pressure bioreactors. Low, medium, and high initial cell seeding "dosing" densities were assayed at subsequent three time points, using eight replicates each (n = 576 biopsies including manufactured scaffold controls). Metabolically viable seeded cells were quantified by MTT assay. Histology defined cell locations and morphology. RESULTS: After 24 h of static seeding with 2.5 × 10(5) cells (medium dose), 100 ± 13 cells/mm(2) (2.5%) attached to leaflets, compared with 193 ± 21 cells/mm(2) (8%) for sinuses. Subsequent 4 d in static culture yielded 894 ± 84 and 838 ± 50 cells/mm(2)versus pulsatile culture yielding 80 ± 12 and 79 ± 12 cells/mm(2) for leaflet and sinus, respectively. However, 76.0% ± 12.2% of cells in leaflets in the pulsatile bioreactor were subsurface as compared to 21.4% ± 3.9% in statically cultured leaflets (P < 0.001). CONCLUSION: Different seeding modes suggest a tradeoff between surface proliferation resulting in higher absolute cell numbers for static seeding versus fewer cells in a cyclic pressure bioreactor but with a greater percentage having migrated into the matrix. The medium seeding dose determined to be optimal is actually feasible for tissue engineering heart valves, and can be achieved by fairly traditional cell amplification methods.

PMID: 21345451 [PubMed - as supplied by publisher]

   
   
Cell origin of human mesenchymal stem cells determines a different healing performance in cardiac regeneration.
February 25, 2011 at 8:38 AM
 

Cell origin of human mesenchymal stem cells determines a different healing performance in cardiac regeneration.

PLoS One. 2011;6(2):e15652

Authors: Gaebel R, Furlani D, Sorg H, Polchow B, Frank J, Bieback K, Wang W, Klopsch C, Ong LL, Li W, Ma N, Steinhoff G

The possible different therapeutic efficacy of human mesenchymal stem cells (hMSC) derived from umbilical cord blood (CB), adipose tissue (AT) or bone marrow (BM) for the treatment of myocardial infarction (MI) remains unexplored. This study was to assess the regenerative potential of hMSC from different origins and to evaluate the role of CD105 in cardiac regeneration. Male SCID mice underwent LAD-ligation and received the respective cell type (400.000/per animal) intramyocardially. Six weeks post infarction, cardiac catheterization showed significant preservation of left ventricular functions in BM and CD105(+)-CB treated groups compared to CB and nontreated MI group (MI-C). Cell survival analyzed by quantitative real time PCR for human GAPDH and capillary density measured by immunostaining showed consistent results. Furthermore, cardiac remodeling can be significantly attenuated by BM-hMSC compared to MI-C. Under hypoxic conditions in vitro, remarkably increased extracellular acidification and apoptosis has been detected from CB-hMSC compared to BM and CD105 purified CB-derived hMSC. Our findings suggests that hMSC originating from different sources showed a different healing performance in cardiac regeneration and CD105(+) hMSC exhibited a favorable survival pattern in infarcted hearts, which translates into a more robust preservation of cardiac function.

PMID: 21347366 [PubMed - in process]

   
   
Fat cells reactivate quiescent neuroblasts via TOR and glial insulin relays in Drosophila.
February 25, 2011 at 8:38 AM
 

Fat cells reactivate quiescent neuroblasts via TOR and glial insulin relays in Drosophila.

Nature. 2011 Feb 23;

Authors: Sousa-Nunes R, Yee LL, Gould AP

Many stem, progenitor and cancer cells undergo periods of mitotic quiescence from which they can be reactivated. The signals triggering entry into and exit from this reversible dormant state are not well understood. In the developing Drosophila central nervous system, multipotent self-renewing progenitors called neuroblasts undergo quiescence in a stereotypical spatiotemporal pattern. Entry into quiescence is regulated by Hox proteins and an internal neuroblast timer. Exit from quiescence (reactivation) is subject to a nutritional checkpoint requiring dietary amino acids. Organ co-cultures also implicate an unidentified signal from an adipose/hepatic-like tissue called the fat body. Here we provide in vivo evidence that Slimfast amino-acid sensing and Target of rapamycin (TOR) signalling activate a fat-body-derived signal (FDS) required for neuroblast reactivation. Downstream of this signal, Insulin-like receptor signalling and the Phosphatidylinositol 3-kinase (PI3K)/TOR network are required in neuroblasts for exit from quiescence. We demonstrate that nutritionally regulated glial cells provide the source of Insulin-like peptides (ILPs) relevant for timely neuroblast reactivation but not for overall larval growth. Conversely, ILPs secreted into the haemolymph by median neurosecretory cells systemically control organismal size but do not reactivate neuroblasts. Drosophila thus contains two segregated ILP pools, one regulating proliferation within the central nervous system and the other controlling tissue growth systemically. Our findings support a model in which amino acids trigger the cell cycle re-entry of neural progenitors via a fat-body-glia-neuroblasts relay. This mechanism indicates that dietary nutrients and remote organs, as well as local niches, are key regulators of transitions in stem-cell behaviour.

PMID: 21346761 [PubMed - as supplied by publisher]

   
     
 
This email was sent to regenmd@gmail.com.
Delivered by Feed My Inbox
PO Box 682532 Franklin, TN 37068
Account Login
Unsubscribe Here Feed My Inbox
 
     

No comments: